Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 563

1.

The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.

Juul KV, Bichet DG, Nielsen S, Nørgaard JP.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F931-40. doi: 10.1152/ajprenal.00604.2013. Epub 2014 Mar 5. Review.

PMID:
24598801
[PubMed - indexed for MEDLINE]
2.

Bilateral papillary renal cell carcinoma and angiomyolipoma in the patients with autosomal dominant polycystic kidney disease: case report of two cases and literature review.

Konosu-Fukaya S, Nakamura Y, Fujishima F, Kasajima A, Takahashi Y, Joh K, Ikeda Y, Ioritani N, Watanabe M, Sasano H.

Pol J Pathol. 2013 Dec;64(4):303-7. Review.

PMID:
24375046
[PubMed - indexed for MEDLINE]
3.

Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

Torres VE, Harris PC.

J Am Soc Nephrol. 2014 Jan;25(1):18-32. doi: 10.1681/ASN.2013040398. Epub 2013 Dec 12. Review.

PMID:
24335972
[PubMed - indexed for MEDLINE]
4.

Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Abu-Wasel B, Walsh C, Keough V, Molinari M.

World J Gastroenterol. 2013 Sep 21;19(35):5775-86. doi: 10.3748/wjg.v19.i35.5775. Review.

PMID:
24124322
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Expanding horizons: ciliary proteins reach beyond cilia.

Yuan S, Sun Z.

Annu Rev Genet. 2013;47:353-76. doi: 10.1146/annurev-genet-111212-133243. Epub 2013 Sep 6. Review.

PMID:
24016188
[PubMed - indexed for MEDLINE]
6.

[Update nephrology 2013].

Schmaderer C, Heemann U, Moog P.

MMW Fortschr Med. 2013 May 16;155(9):56-9; quiz 60-1. Review. German. No abstract available.

PMID:
23951664
[PubMed - indexed for MEDLINE]
7.

[Gene diagnosis and clinical characteristics of autosomal recessive polycystic kidney disease].

Liu SP, Ding J.

Zhonghua Er Ke Za Zhi. 2013 Apr;51(4):311-3. Review. Chinese. No abstract available.

PMID:
23927809
[PubMed - indexed for MEDLINE]
8.

[Progressive renal diseases: recent advances in diagnosis and treatments. Topics: II. Pathophysiology and treatments; 8. Autosomal dominant polycystic kidney disease].

Mochizuki T.

Nihon Naika Gakkai Zasshi. 2013 May 10;102(5):1159-65. Review. Japanese. No abstract available.

PMID:
23847981
[PubMed - indexed for MEDLINE]
9.

[Transcatheter renal arterial embolization therapy on patients with polycystic kidney disease].

Suwabe T, Ubara Y, Takaichi K.

Nihon Jinzo Gakkai Shi. 2013;55(4):541-8. Review. Japanese. No abstract available.

PMID:
23819381
[PubMed - indexed for MEDLINE]
10.

Evaluation of hepatic cystic lesions.

Lantinga MA, Gevers TJ, Drenth JP.

World J Gastroenterol. 2013 Jun 21;19(23):3543-54. doi: 10.3748/wjg.v19.i23.3543. Review.

PMID:
23801855
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Blanco G, Wallace DP.

Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F797-812. doi: 10.1152/ajprenal.00248.2013. Epub 2013 Jun 12. Review.

PMID:
23761677
[PubMed - indexed for MEDLINE]
12.

mTOR and regulation of energy homeostasis in humans.

Mannaa M, Krämer S, Boschmann M, Gollasch M.

J Mol Med (Berl). 2013 Oct;91(10):1167-75. doi: 10.1007/s00109-013-1057-6. Epub 2013 Jun 12. Review.

PMID:
23756767
[PubMed - indexed for MEDLINE]
13.

Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease.

Devuyst O, Torres VE.

Curr Opin Nephrol Hypertens. 2013 Jul;22(4):459-70. doi: 10.1097/MNH.0b013e3283621510. Review.

PMID:
23736843
[PubMed - indexed for MEDLINE]
14.

New treatments for autosomal dominant polycystic kidney disease.

Chang MY, Ong AC.

Br J Clin Pharmacol. 2013 Oct;76(4):524-35. doi: 10.1111/bcp.12136. Review.

PMID:
23594398
[PubMed - indexed for MEDLINE]
15.

Polycystin-1C terminus cleavage and its relation with polycystin-2, two proteins involved in polycystic kidney disease.

Bertuccio CA, Caplan MJ.

Medicina (B Aires). 2013;73(2):155-62. Review.

PMID:
23570767
[PubMed - indexed for MEDLINE]
Free Article
16.

Autosomal dominant polycystic kidney disease: new insights into treatment.

Helal I.

Saudi J Kidney Dis Transpl. 2013 Mar;24(2):230-4. Review.

PMID:
23538343
[PubMed - indexed for MEDLINE]
Free Article
17.

Polycystic kidney disease: new horizons and therapeutic frontiers.

Czarnecki PG, Steinman TI.

Minerva Urol Nefrol. 2013 Mar;65(1):61-8. Review.

PMID:
23538311
[PubMed - indexed for MEDLINE]
18.

Vasopressin: a novel target for the prevention and retardation of kidney disease?

Bankir L, Bouby N, Ritz E.

Nat Rev Nephrol. 2013 Apr;9(4):223-39. doi: 10.1038/nrneph.2013.22. Epub 2013 Feb 26. Review.

PMID:
23438973
[PubMed - indexed for MEDLINE]
19.

TRP channels as therapeutic targets in kidney disease and hypertension.

Menè P, Punzo G, Pirozzi N.

Curr Top Med Chem. 2013;13(3):386-97. Review.

PMID:
23432067
[PubMed - indexed for MEDLINE]
20.

Multidrug therapy for polycystic kidney disease: a review and perspective.

Aguiari G, Catizone L, Del Senno L.

Am J Nephrol. 2013;37(2):175-82. doi: 10.1159/000346812. Epub 2013 Feb 15. Review.

PMID:
23428809
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk